Justesen Ulrik S, Ellebæk Mark B, Qvist Niels, Iachina Maria, Frimodt-Møller Niels, Søes Lillian M, Skovgaard Sissel, Lemming Lars, Samulioniene Jurgitta, Andersen Steen L, Dessau Ram B, Møller Jens K, Coia John E, Gradel Kim O
Department of Clinical Microbiology, Odense University Hospital, Odense 5000, Denmark; Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark; Department of Surgery, Odense University Hospital, Odense 5000, Denmark.
J Infect. 2024 Aug;89(2):106212. doi: 10.1016/j.jinf.2024.106212. Epub 2024 Jul 2.
We aimed to identify specific anaerobic bacteria causing bacteraemia and a subsequent diagnosis of colorectal cancer.
A nationwide population-based cohort study, which included all episodes of defined specific anaerobic bacteraemia from 2010 (5,534,738 inhabitants) through 2020 (5,822,763 inhabitants) and all cases of colorectal cancer diagnosed from 2010 through 2021 in Denmark. We calculated the incidence and risk of colorectal cancer after bacteraemia with specific anaerobic bacteria using Escherichia coli bacteraemia as reference.
Nationwide data on colorectal cancer and specific anaerobic bacteraemia (100% complete, representing 11,124 episodes). The frequencies of colorectal cancer within one year following anaerobic bacteraemia were higher for species, which almost exclusively reside in the colon, such as Phocaeicola vulgatus/dorei (5.5%), Clostridium septicum (24.2%), and Ruminococcus gnavus (4.6%) compared to 0.6% in 50,650 E. coli bacteraemia episodes. Bacteroides spp. had a subhazard ratio for colorectal cancer of 3.9 (95% confidence interval [CI], 3.0 to 5.1) and for Clostridium spp. it was 8.9 (95% CI, 6.7 to 11.8, with C. septicum 50.0 [95% CI, 36.0 to 69.5]) compared to E. coli (reference).
This nationwide study identified specific colorectal cancer-associated anaerobic bacteria, which almost exclusively reside in the colon. Bacteraemia with these bacteria could be an indicator of colorectal cancer.
我们旨在确定导致菌血症并随后诊断为结直肠癌的特定厌氧细菌。
一项基于全国人群的队列研究,纳入了2010年(5534738名居民)至2020年(5822763名居民)期间所有明确的特定厌氧菌血症发作病例,以及2010年至2021年在丹麦诊断出的所有结直肠癌病例。我们以大肠杆菌菌血症为参照,计算特定厌氧细菌菌血症后结直肠癌的发病率和风险。
关于结直肠癌和特定厌氧菌血症的全国性数据(100%完整,代表11124次发作)。与50650次大肠杆菌菌血症发作中的0.6%相比,在厌氧菌血症后一年内,几乎仅存在于结肠的细菌种类,如普通拟杆菌/多雷拟杆菌(5.5%)、败血梭菌(24.2%)和纤细瘤胃球菌(4.6%),结直肠癌的发生率更高。与大肠杆菌(参照)相比,拟杆菌属导致结直肠癌的亚风险比为3.9(95%置信区间[CI],3.0至5.1),梭菌属为8.9(95%CI,6.7至11.8,其中败血梭菌为50.0[95%CI,36.0至69.5])。
这项全国性研究确定了几乎仅存在于结肠的与结直肠癌相关的特定厌氧细菌。这些细菌引起的菌血症可能是结直肠癌的一个指标。